Immunomedics, Inc.

Odeh v. Immunomedics, Inc., No. 2:18-cv-17645 (D. N.J.)

Stock ticker:
IMMU

This lawsuit alleges that Defendants made materially false and misleading statements and omissions about Immunomedics' receipt of and approach to handling a Form 483 from the Food and Drug Administration, which ultimately caused the Company's new drug application to fail.

Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.

The Court denied Defendants’ Motion to Dismiss on July 31, 2020. There is not yet a trial schedule in place.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.